Eli Lilly will soon release key data on its weight loss pill orforglipron

Eli Lilly's weight loss drug slashes the risk of diabetes in long-term trial

FDA approves new Alzheimer's treatment, donanemab from Eli Lilly

Alphabet Taps Eli Lilly Executive as New CFO Replacing Porat